MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Multimodal imaging analysis of autosomal recessive Parkinson’s disease.

    B. Soydas-Turan, G. Yalcin-Cakmakli, E. Yetim, B. Volkan-Salanci, E. Lay-Ergun, K. Karli-Oguz, B. Elibol (Ankara, Turkey)

    Objective: To explore whether autosomal recessive forms of monogenic PD (mPD) might lead to cortical and white matter (WM) abnormalities in addition to dopaminergic denervation.…
  • 2023 International Congress

    Novel CACNA1A splice site variant associated with cerebellar ataxia and mild cognitive impairment; case report of Czech family.

    A. Afifi, M. Nevrly, Z. Musova, P. Hedvicakova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: To describe a case of two related individuals with cerebellar ataxia with a novel variant in the calcium voltage-gated channel subunit alpha1-A (CACNA1A) gene.…
  • 2023 International Congress

    Prodromal stage early biomarkers in Parkinson’s disease and parkinsonism in Uzbek nationality

    DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Evaluation of prodromal stage biomarkers in Parkinson's disease and their role in disease progression Background: From a pathophysiological point of view, PD is characterized…
  • 2023 International Congress

    Development of potent, orally bioavailable, and highly selective LRRK2 PROTAC® degrader molecules as potential disease modifying therapeutics for Parkinson’s disease

    K. Kelly, J. Meredith, L. Kimmel, S. Sparks, A. Desantis, D. Bryce, R. Wilson, J. Corradi, S. Keenan, G. Cadelina, J. Pizzano, A. Cacace (New Haven, USA)

    Objective: Report on the pharmacological characteristics of small molecule PROteolysis TArgeting Chimera (PROTAC) molecules designed to induce degradation of leucine rich repeat kinase 2 (LRRK2)…
  • 2023 International Congress

    Differential effect of MAPT haplotype on survival in CBD and PSP-SCB phenotype

    A. Gharbi, I. Sghaier, I. Kacem, S. Mrabet, A. Souissi, A. Gargouri, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: Evaluate the association of MAPT haplotype with the risk of PSP-CBS and CBD severity of tau pathology by studying the survival rate of both…
  • 2023 International Congress

    Measures of trancranial magnetic evoked potentials for prediction of response to ventriculoparitoneal shunt In normal pressure hydrocephalus

    T. Davidy, S. Anis, A. Sominski, J. Zauberman, T. Fay-Karmon, O. Lesman-Segev, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: Assess the utility of an EEG-TMS-based evaluation for prediction of response to ventriculoperitoneal shunt (VPS) in normal pressure hydrocephalus (NPH). Background: VPS is the…
  • 2023 International Congress

    Unveiling the role of subthalamic nucleus stimulation on freezing of gait in Parkinson disease using wearable sensors

    R. Barbosa, P. Pita Lobo, A. Valadas, P. Bastos, S. Alberto, L. Correia Guedes, M. Rosa, R. Matias, M. Coelho (Toulouse, France)

    Objective: Objectives: To determine whether Deep Brain Stimulation on the Subthalamic nucleus (STN-DBS) is responsible for post-surgery de novo On-State Freezing-of-Gait (FOG) in PD patients, and…
  • 2023 International Congress

    self-compassion, trait worry and sleep in parkinson’s disease (PD) patients

    M. Cusnir, S. Diaconu, E. Ungureanu, B. Ciopleiasb, R. Zosin, I. Murasan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: to evaluate possible interactions between measures ofself-compassion, trait worry and sleep in Parkinson’s Disease (PD) patients. Background: PD patients often experience states of persistent…
  • 2023 International Congress

    DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis

    G. Andraos, N. Ahmed, V. Veerappan (Greer, USA)

    Objective: We present a unique clinical case of antibody positive Muscle Specific Kinase (MuSK) Myasthenia Gravis and DaT scan positive Parkinson's Disease to highlight the…
  • 2023 International Congress

    Sleep-Wake Dependent Modulation in Pallidal Beta and High-Frequency Oscillations in Parkinson’s Disease

    A. Verma, S. Acosta-Lenis, J. Aman, J. Wang, A. Pearson, M. Hill, R. Patriat, S. Cooper, M. Park, N. Harel, M. Howell, C. Mackinnon, J. Vitek, L. Johnson (Minneapolis, USA)

    Objective: To characterize the dynamics of oscillatory activity in the globus pallidus internus (GPi) across the sleep-wake cycle in people with Parkinson’s disease (PD) with…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley